Carlo L Romanò1, Lorenzo Monti2, Nicola Logoluso2, Delia Romanò2, Lorenzo Drago3. 1. Department of Bone and Joint Infections and Reconstructive Surgery, IRCCS Orthopaedic Institute Galeazzi, Via Riccardo Galeazzi 4, 20161, Milan, Italy. carlo.romano@grupposandonato.it. 2. Department of Bone and Joint Infections and Reconstructive Surgery, IRCCS Orthopaedic Institute Galeazzi, Via Riccardo Galeazzi 4, 20161, Milan, Italy. 3. Laboratory of Clinical Chemistry and Microbiology, IRCCS Orthopedic Institute Galeazzi, Via Riccardo Galeazzi 4, 20161, Milan, Italy.
Abstract
PURPOSE: The aim of the present study was to assess the efficacy of a thrombin-based topical haemostatic in reducing blood requirements after total knee replacement (TKR) revision surgery. METHODS: This prospective, randomized, controlled study was designed to evaluate the haemostatic efficacy and safety of a thrombin-based topical haemostatic (Floseal) versus standard treatment in patients receiving total knee revision arthroplasty. The decrease in haemoglobin values postsurgery and the blood units transfused were recorded. The decision to transfuse was made by a surgeon blinded to the patient's group allocation. RESULTS:Forty-eight patients were enroled in the study; twenty-four patients each were randomized to the treatment and control groups, respectively. The median decrease in haemoglobin concentration on the first postoperative day was 2.2 g/dL in the treatment group and 2.7 g/dL in the control group. A significant reduction in units of blood transfused was also observed in the treatment group compared with the control group [1.1 ± 1.13 (range 0-4) vs. 1.9 ± 1.41 (range 0-5) blood units; P = 0.04]. No major treatment-related adverse events were recorded in the study. CONCLUSIONS: This study shows that a thrombin-based topical haemostatic reduces the need for blood transfusion in TKR revision surgery. CLINICAL RELEVANCE: A thrombin-based topical haemostatic agent can be an appropriate solution to enhance haemostasis and vessel sealing at the operative site in TKR revision surgery, in order to reduce the need for blood transfusion after surgery. LEVEL OF EVIDENCE: II.
RCT Entities:
PURPOSE: The aim of the present study was to assess the efficacy of a thrombin-based topical haemostatic in reducing blood requirements after total knee replacement (TKR) revision surgery. METHODS: This prospective, randomized, controlled study was designed to evaluate the haemostatic efficacy and safety of a thrombin-based topical haemostatic (Floseal) versus standard treatment in patients receiving total knee revision arthroplasty. The decrease in haemoglobin values postsurgery and the blood units transfused were recorded. The decision to transfuse was made by a surgeon blinded to the patient's group allocation. RESULTS: Forty-eight patients were enroled in the study; twenty-four patients each were randomized to the treatment and control groups, respectively. The median decrease in haemoglobin concentration on the first postoperative day was 2.2 g/dL in the treatment group and 2.7 g/dL in the control group. A significant reduction in units of blood transfused was also observed in the treatment group compared with the control group [1.1 ± 1.13 (range 0-4) vs. 1.9 ± 1.41 (range 0-5) blood units; P = 0.04]. No major treatment-related adverse events were recorded in the study. CONCLUSIONS: This study shows that a thrombin-based topical haemostatic reduces the need for blood transfusion in TKR revision surgery. CLINICAL RELEVANCE: A thrombin-based topical haemostatic agent can be an appropriate solution to enhance haemostasis and vessel sealing at the operative site in TKR revision surgery, in order to reduce the need for blood transfusion after surgery. LEVEL OF EVIDENCE: II.
Authors: Peter A M Everts; Roger J J Devilee; Cornelis J M Oosterbos; Christine Brown Mahoney; Maarten Eeftinck Schattenkerk; Johannes T A Knape; André van Zundert Journal: Knee Surg Sports Traumatol Arthrosc Date: 2007-02-24 Impact factor: 4.342
Authors: Steven M Kurtz; Kevin L Ong; Edmund Lau; Marcel Widmer; Milka Maravic; Enrique Gómez-Barrena; Maria de Fátima de Pina; Valerio Manno; Marina Torre; William L Walter; Richard de Steiger; Rudolph G T Geesink; Mikko Peltola; Christoph Röder Journal: Int Orthop Date: 2011-03-15 Impact factor: 3.075
Authors: Francisco Mesa-Ramos; Manuel Mesa-Ramos; Carmen Maquieira-Canosa; Pedro Carpintero Journal: Acta Orthop Belg Date: 2008-02 Impact factor: 0.500
Authors: Giuseppe Nasso; Felice Piancone; Raffaele Bonifazi; Vito Romano; Giuseppe Visicchio; Carlo Maria De Filippo; Barbara Impiombato; Flavio Fiore; Francesco Bartolomucci; Francesco Alessandrini; Giuseppe Speziale Journal: Ann Thorac Surg Date: 2009-11 Impact factor: 4.330
Authors: Luigi Sabatini; Andrea Trecci; Daniele Imarisio; Marco Davide Uslenghi; Giuseppe Bianco; Roberto Scagnelli Journal: J Orthop Traumatol Date: 2012-05-16